MTOR and cancer: Recently NOD-like receptor family CARD domain containing 3 (NLRC3) has been identified as the upstream negative molecule in PI3K/Akt/mTOR signaling axis to inhibit the activation of PI3K, Akt and mTOR in cancer (Karki et al., 2016).